BET206-01

N/A

Report date: 2025/02/20 16:25:06

Base Information

Drug NameBET206-01
Drug Alias NameBET206-01BET-206-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionInterleukin-4 receptor subunit alpha inhibitorsThymic stromal lymphopoietin inhibitors
TargetsInterleukin-4 receptor subunit alphaThymic stromal lymphopoietin
Therapy Area/IndicationsDermatitis, AtopicAsthmaRhinitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicAsthmaRhinitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A